Navigation Links
HIV and malaria combine to adversely affect pregnant women and their infants

PAM, Kain and his team collected samples from women in the first pregnancy as well as from women in their subsequent ones living in the Kenyan region where malaria is common. The researchers demonstrated that protection to PAM is mediated by a special type of antibody that allows women to preferentially clear the parasites in their placentas. They found that HIV-infected women lose these antibodies and again become susceptible to the ravages of PAM.

The findings, according to Kain, may help in the development of PAM vaccines. "This is only the first step in creating therapeutics to treat this devastating disease," he stresses. "We hope to help translate this knowledge into more effective vaccines designed to generate these types of protective antibodies."
'"/>

Source:University of Toronto


Page: 1 2

Related biology news :

1. Scientists reveal molecular secrets of the malaria parasite
2. Simple drug has the potential to save many lives threatened by malaria
3. Molecular models advance the fight against malaria
4. Reducing malarial transmission in Africa
5. Sickle cell and protection against malaria
6. Chemists synthesize molecule that helps body battle cancers, malaria
7. Gene expands malarias invasion options
8. University of Nevada, Reno research team discovers hormone that causes malaria mosquito to urinate
9. Measuring hidden parasites in falciparum malaria
10. Old drug, new tricks: Prospects for slashing the impact of malaria
11. Researchers discover how malaria parasite disperses from red blood cells
Post Your Comments:
(Date:6/17/2013)... with central nervous system infections may well be suffering ... to a study to be published in mBio ... for Microbiology. Researchers have detected the virus in spinal ... nervous system infections of unknown cause, and in an ... and poultry, suggesting animals may serve as reservoirs for ...
(Date:6/17/2013)... 2013How kids eat their food may turn out to be ... new study out of St. Michael,s Hospital. , The ... a significant association between poor eating habits in kids ... or "bad" cholesterol, putting them at risk for cardiovascular ... the Canadian Medical Association Journal today. , ...
(Date:6/17/2013)... original foundations with more modern elements. Using this same ... P. Dietrich School of Arts and Sciences have designed ... gas storage, and gas transport more efficient and at ... latest issue of the Journal of the American ... work builds upon Pitt Associate Professor of Chemistry Nathaniel ...
Breaking Biology News(10 mins):New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3Poor eating behaviors may put preschoolers at risk for later health problems 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... for life on Earth stretches back billions of years, ... When multi-celled animal life appeared on the planet after ... rapidly. Conventional wisdom has it that animal ... much later in Earth history to terrestrial environments. ...
... Okla. In a first to the state of ... Natural Resources will receive $226,890 in grant funding from ... Resources Research Institute. OWRRI and USGS officials are ... the water cycle in the tallgrass prairie, two key ...
... nation-wide estimate of the tiger population brought a positive ... the Nepal Government,s Department of National Parks and Wildlife ... 194) breeding tigers in the wild within the four ... was jointly implemented by the DNPWC, Department of Forests ...
Cached Biology News:Earliest animals lived in a lake environment, research shows 2Earliest animals lived in a lake environment, research shows 3Key OSU water research receives national funding 2121 breeding tigers estimated to be found in Nepal 2
(Date:6/19/2013)... 2013 Express Diagnostics Int’l, Inc., manufacturer ... that it has received Class III medical device license ... DrugCheck® NxStep Onsite Drug Screen Cup in ... screening device in near-patient settings, such as physicians’ offices. ... Health Canada Class III approval for 24 different drugs ...
(Date:6/18/2013)... HONG KONG, June 18, 2013 China Cord ... the "Company"), China,s leading provider of cord blood collection, ... storage services, today announced its preliminary unaudited financial results ... year 2013 ended March 31, 2013. ... for the fourth quarter of fiscal 2013 increased by ...
(Date:6/18/2013)... June 18, 2013 Demanding industrial and ... engineered of synthetic Sapphire and Glass Ball Lenses, now ... Swiss Jewel Company , of Philadelphia , PA. ... and collimating the light beams without the need for ... and natural durability (9 mohs) make it the ideal ...
(Date:6/18/2013)... 18, 2013 RegeneCure announced ...  proprietary AMCA Guided Bone Regeneration (GBR) Dental Membrane as a ... A common problem encountered when patients have a tooth replaced ... volume to house the implant. Consequently there is often a ... the natural bone regenerates. The bone substitute material, in turn, ...
Breaking Biology Technology:Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3
... May 15 DOR BioPharma, Inc. (OTC Bulletin Board: ... today announced its financial results for the first quarter ... 2009 were approximately $0.5 million compared to $0.7 million ... revenues were primarily attributable to decreased research and development ...
... ENMD-2076 Clinical Program Adds Leukemia Clinical Study and Orphan ... ENMD ), a clinical-stage pharmaceutical company developing ... for three of its clinical-stage drug candidates at the ... be held May 29 - June 2, 2009 in ...
... with unionsSEATTLE, May 15 Cell Therapeutics, Inc. (CTI) ... discussed in a press release on February 27, 2009, ... reached agreement with the employee union on a severance ... CTI,s total headcount in Italy by 56 positions in ...
Cached Biology Technology:DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 5EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 2EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 3EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 4EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 5Cell Therapeutics Closes Italian Facility, Reduces Headcount and Expects to Cut $14 Million in Operating Expenses 2
... expression of an N-terminal FLAG® fusion and ... marker from bicistronic mRNA. Two genes ... for transcription of a single message from ... for protein-protein interaction studies, multi-subunit proteins, and ...
...
Mouse monoclonal antibody raised against a partial recombinant SCARB2. NCBI Entrez Gene ID = SCARB2...
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: